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Squamous cell carcinoma (SCC) is one of themost common cancers of the head and neck region worldwide and is generally treated
surgically in combination with radiotherapy and/or chemotherapy. However, anticancer agents have numerous serious side effects,
and alternative, less toxic agents that are effective as chemotherapeutics for SCC are required.The Paeoniaceae family is widely used
in traditional Chinese medicine. We examinedmethanol and butanol extracts of Paeonia lutea (P. lutea) leaves for their potential as
an anticancer agent. Both extracts decreased the proliferation of SCC cells, induced apoptotic cell death, and modulated migration,
adhesion, chemotaxis, and haptotaxis in an extracellular matrix- (ECM-) dependent manner due to altered expression of several
integrin subunits. Subsequently, SCC cells were subcutaneously transplanted into athymic nude mice; the extracts reduced the
metastasis of SCC cells but had little effect on the volume of the primary tumor or survival or body weight of the mice. The results
suggest that the extracts may hold promise for preventing cancer metastasis.
1. Introduction
Squamous cell carcinoma (SCC) is one of the most com-
mon cancers of the head and neck region worldwide, with
more than sixty thousand patients diagnosed each year
[1]. Commonly, SCC is treated surgically in combination
with radiotherapy and/or chemotherapy. However, treatment
outcome is unsatisfactory, with 20% to 50% of patients
developing regional recurrence and/or distant metastasis
[2]. In addition, anticancer agents often cause a variety of
serious side effects; for example, cis-platinum (II) diammine
dichloride (CDDP), which is often used for chemotherapy
of SCC, causes nephrotoxicity [3], neurotoxicity [4], nausea,
vomiting [5], ototoxicity [6], and xerostomia (dry mouth) [7,
8]. Hence, less toxic chemotherapeutics for SCC are required.
The Paeoniaceae family is widely used in traditional Chi-
nese medicine. Previous studies reported that the root barks
of Paeoniaceae are used as therapeutics for various diseases
such as diabetes [9], Alzheimer’s disease [10, 11], arthritis [12],
inflammation [13], sepsis [14], brain-ischemia-reperfusion
injury [15], and virus infections [16, 17]. Moreover, several
studies have reported anticancer effects of Paeoniaceae family
preparations [18–23].
Traditional Chinese medicine has been used to treat a
variety of diseases for several thousands of years; therefore,
we launched an interinstitutional collaborative project in 2010
to evaluate the therapeutic potential of herbal extracts for
disorders of the head and neck region [23–26]. Here, we
examined methanol and butanol extracts of Paeonia lutea (P.
lutea) leaves for their potential as an anticancer agent. Our
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results indicate that these extracts modulate the migration
and adhesion of SCC cells to the extracellular matrix (ECM)
by altering integrin subunit expression in vitro and reduce
metastasis of the cells in vivo; however, transplanted tumor
growth and survival of the recipient animals were essentially
unaffected.
2. Materials and Methods
2.1. Plant Materials and Preparation of Plant Extracts. P.
lutea leaves were collected from Tsukuba Peony Garden
(Tsukuba, Ibaraki, Japan) in October 2012. A voucher speci-
men (UTHS1210) was deposited at the Laboratory of Natural
Products Chemistry, Graduate School of Life and Environ-
mental Sciences, University of Tsukuba. The leaves were air
dried for 2 days at room temperature (dry weight, 350 g)
and then extracted with methanol (4 L) for 1 week. The
extraction was repeated once. The two methanol extracts
were combined and concentrated in vacuo at 38∘C to give the
methanol extract (ME, 80.1 g). The extract was partitioned
with ethyl acetate three times (800mL each) and H
2
O
(800mL). The ethyl acetate was evaporated to afford ethyl
acetate soluble materials (EA, 28.5 g). The H
2
O layer was
partitioned with butanol three times (600mL each) to give
butanol-soluble (BU, 20.5 g), butanol-insoluble (BW, 2.1 g),
and H
2
O-soluble materials (W, 16.5 g). Finally, aliquots of
each of these materials were dissolved in phosphate-buffered
saline (PBS) at a concentration of 1mg/mL and sterilized
by passage through a Millex syringe filter (Merck Millipore,
Billerica, MA).
2.2. Cell Culture and Anchorage-Independent Growth Assay.
SAS cells, a human oral SCC cell line [27], were cultured in
high-glucose Dulbecco’s Modified Eagle Medium (DMEM;
Wako, Osaka, Japan) supplemented with 10% fetal bovine
serum (FBS) and penicillin-streptomycin solution (Sigma-
Aldrich, St. Louis, MO) at 37∘C, 5% CO
2
, and 100% humidity.
Anchorage-independent growth assay was carried out using
a commercial kit (Cytoselect 96-Well In Vitro Tumor Sensi-
tivity Assay kit, Cell Biolabs, San Diego, CA) as described
previously [28].
2.3. Cell Growth and Apoptosis Assays. One thousand cells
were seeded into each well of a 96-well tissue culture plate.
After 48 h, the cells were assayed using the tetrazolium salt 3-
[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide
(MTT) assay, as described previously [29]. The activities
of caspases 3/7, 8, and 9 were measured using a Caspase-
Glo (Promega, Madison, WI) and GloMax-Multi+ Detection
System (Promega) according to the manufacturer’s protocol.
Genomic DNA fragmentation was investigated using a com-
mercial kit (Apopladder EX; Takara, Shiga, Japan) according
to the manufacturer’s protocol.
2.4. Protein Preparation and Western Blotting Analysis. Total
cellular protein was prepared as described previously [30].
Protein concentration was measured using Quick Start Brad-
ford Reagent (Bio-Rad, Hercules, CA) using bovine serum
albumin (BSA) as a standard. Protein aliquots were stored
at −80∘C until use. For Western blot analysis, 20𝜇g of total
cellular protein was subjected to sodium dodecyl sulfate
polyacrylamide electrophoresis (SDS-PAGE) on a 4% to 20%
gradient gel (Bio-Rad); then the blot was transferred onto
a polyvinylidene difluoride membrane (Life Technologies,
Carlsbad, CA). Blocking, 1st and horseradish-peroxidase-
conjugated 2nd antibody reactions and washing were con-
ducted as previously described [28]. The chemiluminescence
signals were visualized using Amersham ECL Western Blot-
ting Detection Reagents (GE Healthcare UK Ltd., Bucking-
hamshire, UK) and ChimiDoc XRS Plus ImageLab System
(Bio-Rad). The 1st and 2nd antibodies were purchased from
common suppliers.
2.5. Adhesion, Wound Healing, and Migration Assays. The
cells were grown in a monolayer culture in the presence
or absence of the various P. lutea leaf extracts. After 3 d,
the cells were assayed. Adhesion and wound healing assays
were carried out using commercial kits (CytoSelect 48-Well
Cell Adhesion Assay, CytoSelect 24-Well Wound Healing
Assay, Cell Biolabs) according to themanufacturer’s protocol.
To assay migration, a chemotaxis chamber containing a
membrane with 8mm pores (Chemotaxicell, Kurabo, Osaka
Japan) was coated with 50𝜇g/mL bovine type I colla-
gen (Koken, Tokyo, Japan) or 50 𝜇g/mL bovine fibronectin
(Sigma-Aldrich) according to the manufacturer’s protocol
and was set into each well of a 24-well culture plate. After
drying the Chemotaxicell membrane, 500 𝜇L of DMEMwith
or without 10% FBS was added to the bottom of the well as
a chemoattractant, 200𝜇L of DMEM containing 2 × 104 cells
was added to the chamber, then the plate was incubated for
24 h at 37∘C, 5% CO
2
, and 100% humidity. The membranes
were then washed, removed from the chamber, fixed with
4% formaldehyde (Wako, Osaka, Japan), and stained with
crystal violet (Wako). The membranes were examined under
an optical microscope and photographs (×400) were taken.
2.6. Animals. The care and treatment of the experimental
animals complied with the Showa University Guidelines for
Animal Experiments, and the experimental protocol was
approved by the Animal Experimentation Committee of
Showa University. The dorsal flank of four-week-old female
athymic Balb/c nu/numice (CLEA Japan, Tokyo) was subcu-
taneously injected with a PBS-suspension of 1 × 106 SAS cells,
as described previously [30]. After 1 week, tumor formation
was measured (approximately 10mm3), and the mice were
divided into 6 groups (control, ME, EA, BU, BW, and W).
Therefore, the 7th day after SAS cell injection was designated
“day 1,” thereafter. Each herbal extract was suspended in PBS
at the concentration of 2mg/mL and 100mg/kg body weight
was orally administrated using a sterilized feeding needle
once every three days for 40 or 70 days. In the control group,
only PBS (0.1mL) was administrated. The body weight and
diameters (large and small) of eachmouseweremeasured and
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the tumor volume was determined by direct measurement
and calculated using the formula [30]𝜋/6× (large diameter)×
(small diameter)2. On day 40 or 70, the mice were sacrificed,
and the tumors together with the surrounding soft tissue,
liver, and lungs were harvested for histochemical analysis.
2.7. Histochemistry and Immunohistochemistry. The tissue
was fixed, embedded, sliced, and subjected to hematoxylin-
eosin (HE) staining as described previously [31]. Immuno-
histochemistry was conducted as described previously [31].
After 24 h incubationwith a 1/50 dilution of primary antibody
for human cytokeratin 10/13 (Santa Cruz Biotechnology,
Santa Cruz, CA), the slide was incubated with Simple Stain
MAX-PO (Nichirei, Tokyo, Japan) and visualized using
Envision HRP/Kit (Dako, Kyoto, Japan); the manufacturer’s
suggested protocol for each commercial kit was used.
2.8. Statistical Analysis. Unless otherwise specified, all exper-
iments were repeated at least twice, and similar results
were obtained in the repeat experiments. Statistical analysis
for mouse survival was determined by the log rank test.
Other statistical analyses were carried out using two-tailed,
unpaired Student’s 𝑡-test. Data are expressed as means ±
standard deviation of at least three data items. A 𝑝 value <
0.05 was considered significant.
3. Results
3.1. Extracts of P. lutea Leaves Decreased Proliferation of SCC
Cells in an Anchorage-Independent Manner, but No EffectWas
Observed on Monolayer Cultures. We first investigated the
effects of the P. lutea leaf extracts on the proliferation of
SCC cells (Figure 1). Only 100 𝜇g/mL EA had a significant
effect on monolayer cultures ((a) and (b)). In contrast, all
extracts showed a significant growth-inhibitory effect on
soft agar cultures using the MTT assay (c). Importantly,
phase-microscopy images (d) indicated that all the extracts
decreased both the number and size of SCC cells compared
to the control culture. These results suggest that extracts of
P. lutea leaves are likely to reduce both the proliferation and
malignancy of SCC cells.
3.2. Extracts of P. lutea Leaves Induce Apoptotic Cell Death of
SCC Cells in Soft Agar Culture. We tested the hypothesis that
the reduced MTT activity was due to apoptotic cell death by
investigating the apoptotic effects of the extracts (Figure 2).
Caspase activity assays (a) revealed that 10–100mg/mL of
EA significantly increased caspase 3/7 and 9 activities in a
monolayer culture, whereas all the extracts strongly increased
caspase activities in a soft agar culture. On the other hand, a
DNA ladder assay (b) showed almost no DNA fragmentation
in monolayer cultures treated with any of the extracts,
whereas significant DNA fragmentation was observed in
all the test soft agar cultures, in disagreement with the
caspase assays. Furthermore, we examined the effects of the
extracts onmodulating apoptosis-related protein expressions
by Western blotting analysis (c). In both monolayer and soft
agar cultures, EA and BU reduced the expression of Bcl-2,
a mitochondrial antiapoptotic protein, but the expression of
other proteins (p53, Bcl-XL, Bax, Bad, Bid, Bak, and XIAP)
was essentially unaltered. These results indicate that EA and
BU might affect the mitochondrial apoptotic pathway, in an
anchorage-independent manner.
3.3. Extracts of P. lutea Leaves Decreased the Adhesion of
ECM. Next, we examined the effects of adhesion, migration,
and invasion in an ECM-dependent manner (Figure 3). Cell
adhesion assays (a) showed that EA and BU reduced the
attachment of SCC cells to type I collagen (Col I) and
fibronectin (FN); similar results regarding cellmigrationwere
obtained using a cell migration assay (b). Furthermore, a
cell invasion assay (c) showed that EA and BA reduced SAS
cell invasion of Col I and FN and that the effects were
independent of a chemoattractant. Those results imply that
EA and BU extracts decrease both chemotaxis and haptotaxis
of SCC cells through the ECM, thereby potentially preventing
the invasion and metastasis of SCC cells.
3.4. Extracts of P. lutea Leaves Decreased the Expression
of Several Integrin Subunits. The adhesion, migration, and
invasion of various cells, including cancer cells, rely on
integrin proteins. We therefore investigated whether the
extracts modulate the expression of major integrin subunits.
Western blotting analysis indicated that BW and W had
little effect on the expression of integrin subunits (Figure 4):
the expression of 𝛼4, 𝛽3, 𝛽4, and 𝛽5 integrin subunits was
attenuated by EA andBU, but expression of the other subunits
was essentially unchanged. These results suggest that the
altered response of SAS cells to the ECM is at least partly due
to modulation of the expression of several integrin subunits.
3.5. Extracts of P. lutea Reduce Metastasis of SCC Cells. The
results of the above in vitro experiments prompted us to
investigate in vivo whether the extracts might be useful as a
novel anticancer medicine. Each extract was orally adminis-
trated to SCC-transplanted nude mice (Figure 5). Contrary
to our expectation, neither survival (a), body weight (b),
nor tumor growth ((c) and (d)) was affected by the extracts
compared to the control group. Furthermore, histochemical
analysis (Figure 6) showed that all extracts had little effect
on the primary tumor. Liver and lung tissues were examined
to determine the effects of the extracts on metastasis. HE
staining showed no obviousmetastatic tumor cells. Immuno-
histochemistry for cytokeratin 10/13, a representative marker
of SCC cells, showed positive cells in the control andME, BW,
and W extracts mice, indicating micrometastasis from the
primary tumor. Interestingly, however, administration of EA
and BU extracts significantly reduced the number of positive
cells. These results indicate that EA and BU extracts of P.
lutea exhibit pharmacological effects to decrease hepatic and
pulmonary metastasis from epidermal SCC and suggest that
the extracts may hold promise as anticancer therapeutics.
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Figure 1: Growth-inhibitory effects of extracts of P. lutea leaves. SAS cells were grown in a monolayer ((a) and (b)) or on soft agar ((c) and
(d)) culture. Methanol (ME), ethyl acetate (EA), butanol (BU), butanol-insoluble (BW), and water (W) extracts of P. lutea leaves were added
to the culture medium at 0 (control) and 1, 10, or 100𝜇g/mL. After 7 d, the cells were subjected to MTT assay ((a) and (c)) and crystal violet
staining (b) or examined under a phase-contrast microscope (d). Data in (a) and (c) are means ± standard deviations of 3 cultures; the mean
of the control cultures is taken as “1.” ∗𝑝 < 0.05 versus control. Bars, 100 𝜇m (b) and 200 𝜇m (d).
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Figure 2: Apoptosis-induced effects of P. lutea leaf extracts. SAS cells were grown in a monolayer or on soft agar culture. Methanol (ME),
ethyl acetate (EA), butanol (BU), butanol-insoluble (BW), and water (W) extracts of P. lutea leaves were added to the culture medium at 1 to
100𝜇g/mL ((a) and (b)), 10 to 100 𝜇g/mL (c), or 0𝜇g/mL (control). After 3 d, the cells were subjected to caspase 3/7, 8, and 9 assays (a), a DNA
ladder assay (b), orWestern blotting analysis for apoptosis-related proteins (p53, Bcl-2, Bcl-XL, Bax, Bad, Bid, Bak, and XIAP) using GAPDH
as an internal control (c). Data in (a) are means ± standard deviations of 3 cultures; the mean of the control cultures is taken as “1.” ∗𝑝 < 0.05
versus control.
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Figure 3: Effects of P. lutea leaf extracts on cell adhesion to ECMs. SAS cells were grown in a monolayer culture in the presence or absence
(control) of methanol (ME), ethyl acetate (EA), butanol (BU), butanol-insoluble (BW), and water (W) extracts of P. lutea leaves at 10 to
100𝜇g/mL. After 3 d, the cells were subjected to adhesion (a), wound healing (b), and migration (c) assays for ECM (type I collagen (Col I),
fibronectin (FN), and BSA) or an uncoated surface (Uncoat). 10% FBS was used as a chemoattractant or not (—) in the migration assay (c).
Bars, 100𝜇m (a and c) and 1mm (b).
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Figure 4: Effects of P. lutea leaf extracts on expression of integrin proteins. SAS cells were grown in a monolayer culture in the presence or
absence (control) of methanol (ME), ethyl acetate (EA), butanol (BU), butanol-insoluble (BW), and water (W) extracts of P. lutea leaves at 10
to 100 𝜇g/mL. After 3 d, total cellular proteins were purified and 20 𝜇g aliquots were subjected to Western blotting for 𝛼1, 𝛼2, 𝛼3, 𝛼4, 𝛼5, 𝛼v,
𝛽1, 𝛽2, 𝛽3, and 𝛽4 integrins. GAPDH was used as an internal control.
4. Discussion
The Paeoniaceae family has been widely used in traditional
Chinese medicine for thousands of years. Recent studies
have revealed that extracts of Paeoniaceae may provide
alternative anticancer therapeutics [18–23] and prompted us
to investigate the extracts of P. lutea leaves for their anticancer
potency. We first conducted in vitro studies to determine
the effects of P. lutea leaf extract on proliferation (Figure 1)
and apoptosis (Figure 2) of SCC cells. The extracts decreased
proliferation and induced apoptotic cell death mainly by a
mitochondrial signaling pathway, similar to Paeoniaceae root
extracts [32]. Interestingly, the effects were more prominent
in anchorage-independent cultures. Since proliferation and
migration in an anchorage-independentmanner reflect prop-
erties of malignant cancer cells [33], those results suggested
that the extracts could be useful as an anticancer agent.
We next examined whether the extracts modulate adhe-
sion to ECM and affect ECM-dependent migration, chemo-
taxis, and haptotaxis (Figure 3). EA and BU extracts signif-
icantly decreased adhesion to Col I and fibronectin. Several
previous studies have reported that adhesion to ECM plays
an important role in the invasion and metastasis of cancer
cells [33, 34].Thus, the present results suggest that the extracts
might also decrease invasion and metastasis. Furthermore,
adhesion between ECM and normal and cancer cells is
supported by integrins, in particular 𝛼5𝛽1 integrin, a main
component of the fibronectin receptor [35]. However, West-
ern blotting analysis for variousmajor integrin subunits (Fig-
ure 4) showed essentially no modulation of the expression of
𝛼5 or 𝛽1 subunits by the extracts, although 𝛼4, 𝛽3, 𝛽4, and 𝛽5
integrin subunit expressionwas suppressed by the EA andBU
extracts. Further studies, for example, on integrin-dependent
signaling pathways and on other adhesion molecules, are
required to resolve this discrepancy. Nevertheless, the present
study demonstrated that EA and BU extracts modulate the
expression of several integrin subunits, thus decreasing the
invasion and metastasis of SCC cells in vitro.
The potential utility of the extracts for clinical use
was investigated by an animal experiment and subsequent
histochemical examination. A dose of 100mg/kg body weight
was chosen based on our previous studies [36–38]. The
extracts were orally administrated to SAS-cell-transplanted
nude mice, and the survival and body weight of the mice and
the volume of the primary tumor were measured (Figure 5).
In contrast to the in vivo results, no antitumor effects
were observed. HE staining and subsequent histochemical
examination of the primary tumor, liver, and lung (Figure 6)
showed no effect of the extracts. Cytokeratin 10/13 is highly
expressed in SCC cells [39, 40], including SAS cells, and
immunohistochemistry for cytokeratin 10/13 is indicative of
metastasis of tumor cells in liver and lung. Mice given the
extracts for 70 days showed positive cells in the organ (liver
and lung). However, administration of EA and BU extracts
significantly decreased the number and size of cytokeratin
10/13-positive tumor cells, suggesting that the extracts may
have potency for reducing hepatic and pulmonary metastasis
of epidermal SCC.
Our results demonstrate that EA and BU extracts of P.
lutea have pharmacological effects of preventing the metasta-
sis of SCC cells. The chemical composition, side effects, and
minimum required dosage of the extracts of the extraction
8 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Effects of P. lutea leaf extracts on mouse survival and tumor growth in SAS-cell-xenograft nude mice. One million SAS cells were
subcutaneously injected into the dorsal flank of nude mice (see Section 2). After 7 d, the mice were divided into 6 groups: vehicle (black
lines in (a), (b), and (c) and control in (d)) methanol (red lines and ME), ethyl acetate (blue lines and EA), butanol (yellow lines and BU),
butanol-insoluble (green lines and BW), and water (orange lines and W) extracts of P. lutea leaves were administrated once every three days
at a concentration of 100mg/kg body weight in PBS. Mouse survival Kaplan Meier plot in %, body weight in grams, and tumor volume in
×103mm3 of each group are depicted in (a), (b), and (c), respectively; images of a representative mouse in each group were taken at d 40 and
70 (d). Bars, 1 cm.
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Figure 6: Effects of P. lutea leaf extracts on hepatic and pulmonary tumor-cell-metastasis in SAS-cell-xenograft nude mice. One million SAS
cells were subcutaneously injected into the dorsal flank of nudemice, and vehicle (control), methanol (ME), ethyl acetate (EA), butanol (BU),
butanol-insoluble (BW), and water (W) extracts of P. lutea leaves were administrated once every three days at 100mg/kg body weight in PBS
(see Section 2). After d 40 or 70, the mice were sacrificed, and the tumors, livers, and lungs were fixed and subjected to HE staining (HE) and
immunohistochemistry for cytokeratin 10/13 (CK 10/13). Bars, 200𝜇m.
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are currently being investigated in detail and will be reported
in the near future.
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